What’s new in surgical treatment of infective endocarditis?

Intensive Care Medicine

Volumn 42, Issue 12, 2016, Pages 2052-2054

  Carrel, Thierry ^a   Englberger, Lars ^a   Takala, Jukka ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; HEART SURGERY; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICAL DECISION MAKING; PROSTHESIS INFECTION; SURVIVAL; COMORBIDITY; CRITICAL ILLNESS; ENDOCARDITIS; MORTALITY; PRACTICE GUIDELINE; RISK FACTOR; TIME FACTOR;

COMORBIDITY; CRITICAL ILLNESS; ENDOCARDITIS; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; TIME FACTORS;

EID: 84988732051     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-016-4542-x     Document Type: Article

References (15)

1. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V et al (2011) Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 306:2239–2247
2. Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E et al (2013) In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med 173:1495–1504
3. Leroy O, Georges H, Devos P, Bitton S, De Sa N, Dedrie C et al (2015) Infective endocarditis requiring ICU admission: epidemiology and prognosis. Ann Intensive Care 5:45
4. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F et al (2015) ESC guidelines for the management.of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS) and the European Association for Nuclear Medicine (EANM). Eur Heart J 36:3075–3123
5. Baddour LM, Wilson WR, Bayer AS, Fowler WG, Tleyjeh IM, Rybak MJ et al (2015) Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. A scientific statement for healthcare professionals from the American Heart Association. Endorsed by the Infectious Diseases Society of America. Circulation 132:1435–1486
6. Anantha Narayan M, Mahfood Haddad T, Kalil AC, Kanmanthareddy A, Suri RM, Mansour G et al (2016) Early versus late surgical intervention or medical management for infective endocarditis: a systematic review and meta-analysis. Heart 102:950–957
7. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC et al (2012) Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 366:2466–2473
8. Mirabel M, Sonneville R, Hajage D, Novy E, Tubach F, Vignon P et al (2014) ENDOREA Study Group. Long-term outcomes and cardaic surgery in critically ill patients with infective endocarditis. Eur Heart J 35:1195–1204
9. Wang TK, Oh T, Voss J, Gamble G, Kang N, Pemberton J (2015) Comparison of contemporary risk scores for predicting outcomes after surgery for active infective endocarditis. Heart Vessels 30:227–234
10. Habib G, Lancellotti P (2015) The 2015 ESC guidelines for the management of infective endocarditis. Take-home message of the full 2015 ESC guidelines, also endorsed by the European Association for Cardio-Thoracic Surgery, European Association of Nuclear Medicine, and European Society of Clinical Microbiology and Infectious Diseases. Eur Heart J 36:3036–3042
11. Mihos CG, Pineda AM, Santana O (2016) A meta-analysis of early versus delayed surgery for valvular infective endocarditis complicated by embolic ischemic stroke. Innovations (Phila) 11(3):187–192
12. Okita Y, Minakata K, Yasuno S, Uozumi R, Sato T, Ueshima K et al (2016) Optimal timing of surgery for active infective endocarditis with cerebral complications: a Japanese multicentre study. Eur J Cardiothorac Surg 50:374–382
13. Sandoe JA, Barlow G, Chambers JB, Gammage M, Guleri M, Howard P et al (2015) Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother 70:325–359
14. Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V, for the AEPEI Study Group et al (2016) Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices. Eur Heart J 37:840–848
15. Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C et al (2015) Association between surgical indications, operative risk and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Circulation 131:131–140